Trials / Unknown
UnknownNCT05965882
A Registry Study of Biomarkers in Ischemic Heart Disease ( BIOMS-IHD )
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Beijing Institute of Heart, Lung and Blood Vessel Diseases · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The registry study aims to discover biomarkers for accurate classification and risk assessment of ischemic heart disease.
Detailed description
The purpose of this study is to discover biomarkers for early identification, diagnosis, molecular classification, and intervention based on the mechanism of ischemic heart disease（IHD）. Using mass spectrometry-based metabolomics and multimodal imaging technology, the study aims to further construct a new system for early risk stratification of IHD based on abnormal metabolites.
Conditions
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2024-06-01
- Completion
- 2024-06-01
- First posted
- 2023-07-28
- Last updated
- 2024-01-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05965882. Inclusion in this directory is not an endorsement.